Professor Ernest Choy, Head of Rheumatology and Translational Research at University Hospital of Wales, and Director of the Cardiff Regional Experimental Arthritis Treatment and Evaluation (CREATE) Centre and Welsh Arthritis Research Network (WARN), gives an overview of biosimilar clinical trials and discusses his personal experience including the unique opportunities and challenges.